Tower Research Capital (TRC)’s Mural Oncology MURA Stock Holding History

Tower Research Capital (TRC)’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,869	Closed	-$3.87K	–	5437
2025 Q3	$3.87K	Sell	1,869 -449	-19%	-$965	﹤0.01%	4437
2025 Q2	$5.72K	Sell	2,318 -264	-10%	-$622	﹤0.01%	4156
2025 Q1	$3.25K	Buy	2,582 +2,057	+392%	+$7.5K	﹤0.01%	4444
2024 Q4	$1.69K	Buy	525 +330	+169%	+$1.16K	﹤0.01%	4978
2024 Q3	$610	Sell	195 -5,957	-97%	-$19.4K	﹤0.01%	5301
2024 Q2	$19.3K	Buy	6,152 +4,945	+410%	+$18.2K	﹤0.01%	3779
2024 Q1	$5.9K	Sell	1,207 -1,319	-52%	-$6.4K	﹤0.01%	4469
2023 Q4	$15K	Buy	+2,526	New	+$10.2K	﹤0.01%	3849

Tower Research Capital (TRC)'s MURA Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 1,869 shares — an estimated $3.87K sold.

Tower Research Capital (TRC) first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $19.3K in Q2 2024. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Tower Research Capital (TRC) reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 1,869 Mural Oncology shares in Q4 2025, an estimated $3.87K.
Tower Research Capital (TRC) first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Tower Research Capital (TRC)'s Mural Oncology position peaked at $19.3K in Q2 2024.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.